Understanding why some children with neuroblastoma have worse survival or respond badly to treatment
Targeting the Fanconi Anaemia pathyway in neuroblastoma
Understanding the genetics of poor outcome neuroblastoma to improve treatment
A genome wide study of unresectable, MYCN non-amplied, unfavourable histology neuroblastomas in patients older than 18 months of age
Discovering what causes Ewing's sarcoma to spread
Identifying molecular drivers of disease progression in Ewing’s sarcoma
Improving our understanding of brain tumours in teenagers and young adults
Teenagers and young adults with primary CNS cancers: a systematic biological characterisation
Investigating the makeup of malignant rhabdoid tumours
RNA‐sequencing to characterise malignant rhabdoid tumour heterogeneity: a pilot study in archival frozen material
Developing a blood test to monitor ependymoma treatment and follow-up
Minimal residual disease detection of ependymoma by microRNA biomarker profile evaluation as part of SIOP Ependymoma II trial
Giving children a voice in healthcare encounters
Giving children a voice in healthcare encounters: Implementing a multi-platform interactive technology with children who have cancer
Using the immune system to improve treatment for Hodgkin lymphoma
Targeting GPNMB in Hodgkin lymphoma
Finding new drugs to treat high-risk rhabdomyosarcoma
High-risk rhabdomyosarcoma patient derived 3D cultures to screen for novel drugs that enhance sensitivity to standard treatment